MedTrace Logo

Hybrid Course Assessment and Evaluation

NCT06409273 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2024-05-14

No results posted yet for this study

Summary

The academic training of French postgraduate students in general practice (E3CMG) is facing a challenge due to the increasing gap between the number of students and the available teaching hours. To accommodate the growing number of students, asynchronous acquisition of knowledge prior to a reduced face-to-face teaching would maintain the capacity to provide socio-constructivist teaching useful for developing problem-solving skills (i.e. thesis design and feasibility assessment). The main objective of this randomized controlled trial is to evaluate the effect of hybrid versus face-to-face socio-constructivist teaching on French E3CMG course assessment and evaluation.

Conditions

  • Education, Medical

Interventions

OTHER

Hybrid course on medical thesis for post graduates general practice students

Students randomised to the intervention group will log on to interactive online teaching for a maximum time of 2.5 hours, and then follow face-to-face socio-constructivist teaching in small groups (n=22 max), building on the knowledge they have acquired. The aim of this peer-to-peer face-to-face teaching is to develop problem-solving skills.

OTHER

Face-to-face teaching on medical thesis for post graduates general practice students

Students randomised to the control group will be taught entirely face-to-face in small groups (n=22 max). The course duration and teaching objectives are identical to those of the intervention group. Student consent and randomization will be carried out on the morning of the course to avoid contamination and attrition bias.

Sponsors & Collaborators

  • Research on Healthcare Performance Lab U1290

    lead OTHER

Principal Investigators

  • Rémy Boussageon, MD, PhD · Lyon 1 University & LBBE UMR 5558, CNRS

  • Marion Lamort-Bouché, MD, PhD · Research on Healthcare Performance Lab U1290, Inserm

  • Pierre-Yves Meunier, MD · University Lyon 1

  • Sophie Schlatter, PhD · Research on Healthcare Performance Lab U1290, Inserm

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-14
Primary Completion
2024-05-21
Completion
2024-11-14

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06409273 on ClinicalTrials.gov